HMGA2 and obesity due to melanocortin 4 receptor deficiency: Due to the importance of HMGA2 in adipogenesis (19) and tumorigenesis (20), HMGA2 is considered a potential therapeutic target for anticancer and anti-obesity treatments (8,21–23).